JP MORGAN/PUT/PFIZER INC/32/0.1/17.01.25 Share Price

Warrant

DE000JS56SB0

Market Closed - Börse Stuttgart 05:18:13 01/07/2024 pm IST
0.44 EUR -4.35% Intraday chart for JP MORGAN/PUT/PFIZER INC/32/0.1/17.01.25
Current month-4.35%
1 month+2.33%
Date Price Change
01/24/01 0.44 -4.35%
28/24/28 0.46 -4.17%
27/24/27 0.48 +17.07%
25/24/25 0.41 -10.87%
24/24/24 0.46 0.00%

Delayed Quote Börse Stuttgart

Last update July 01, 2024 at 05:18 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellPUT
Underlying PFIZER, INC.
Issuer J.P. Morgan
WKN JS56SB
ISINDE000JS56SB0
Date issued 10/02/2023
Strike 32 $
Maturity 17/01/2025 (200 Days)
Parity 10 : 1
Emission price 0.16
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.69
Lowest since issue 0.17
Delta-0.69x
Omega 4.151
Premium3.16x
Gearing6.04x
Moneyness 1.134
Difference Strike 3.78 $
Difference Strike %+11.81%
Spread 0.01
Spread %2.27%
Theoretical value 0.4350
Implied Volatility 27.43 %
Total Loss Probability 23.61 %
Intrinsic value 0.3519
Present value 0.0831
Break even 27.33 €
Theta-0x
Vega0.01x
Rho-0.01x

Company Profile

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Sector
-
More about the company

Ratings for Pfizer, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Pfizer, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
24
Last Close Price
28.22 USD
Average target price
31.92 USD
Spread / Average Target
+13.10%
Consensus